Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · IEX Real-Time Price · USD
12.24
-0.65 (-5.04%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $501.22 million as of July 2, 2024. Its market cap has increased by 148.38% in one year.
Market Cap
501.22M
Enterprise Value
241.72M
1-Year Change
148.38%
Ranking
Category
Stock Price
$12.24
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $501.22M, a decrease of -23.80%. That is a compound annual growth rate of -14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 527.80M | 19.20% |
| Dec 29, 2023 | 442.80M | 154.04% |
| Dec 30, 2022 | 174.30M | -73.50% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 539.82M |
| iTeos Therapeutics | 536.06M |
| Applied Therapeutics | 533.63M |
| Adaptive Biotechnologies | 533.47M |
| SI-BONE | 532.78M |
| Aveanna Healthcare Holdings | 530.97M |
| Y-mAbs Therapeutics | 530.10M |
| Entrada Therapeutics | 529.05M |